Changes in prostatic cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience

Anal Quant Cytol Histol. 2008 Jun;30(3):152-9.Links Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience.Bollito E, Terrone C, Volpe A, Porpiglia F, Cracco C, Poggio M, Grande S, Righi L, Bellina M, Papotti M, Scarpa RM. Department of Pathology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy. OBJECTIVE: To assess changes in prostate cancer clinical and pathologic features by review of 15 years' experience with radical prostatectomy. STUDY DESIGN: A total of 596 consecutive patients who underwent open or laparoscopic radical prostatectomy (RP) between 1991 and 2006 were included. All had clinically localized prostate cancer. Surgical specimens were analyzed or blindly reviewed by a uropathologist, and whole-mount sections were prepared. Statistical analysis evaluated whether significant changes in clinical and pathologic variables occurred over time. RESULTS: Median prostate specific antigen (PSA) values at diagnosis significantly decreased over time. Definite stage migration was observed, with significant increase of organ-confined tumors. Incidence of seminal vesicle and lymph node involvement declined steadily. Median tumor volume decreased significantly over time (p<0.001). Incidence of nonsignificant cancers at RP increased significantly, reaching 25.6% in 2006. PSA value has progressively lost correlation with prostate cancer volume and today correlates only with prostate gland volume. CONCLUSION: Prostate cancer stage and volume at diagnosis have steadily decreased in the last 15 years, likely reflecting increasing use of PSA testing. In early prostate cancer, PSA level no longer correlates with tumor volume. PMID: 18630840 [PubMed - indexed for MEDLINE]